Zyla Life Sciences Asset Impairment Charges
Zyla Life Sciences reported Asset Impairment Charges of $6.89 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2020-03-26
- Zyla Life Sciences asset impairment charges for the quarter ending 2018-12-31 was $0.00.
- Zyla Life Sciences asset impairment charges for fiscal 2018 was $6.89M.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $6.89M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $6.89M 10-Q · filed 2019-11-14 |